phase readout

NCT05005728: XmAb®20717 (Vudalimab) Alone or in Combination With Chemotherapy or Targeted Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer

COMPLETEDupdated 15d ago

community read0 votes

Sponsor: Xencor, Inc.. Phase: PHASE2. Conditions: Metastatic Castration-Resistant Prostate Cancer

Data sources

last refreshed 11m ago

Found something off?

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?